Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy

被引：4

作者：

Pravettoni V. ^{[1
]}

Piantanida M. ^{[1
]}

Primavesi L. ^{[1
]}

Forti S. ^{[2
]}

Pastorello E.A. ^{[3
]}

机构：

[1] Clinical Allergy and Immunology Unit, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan

[2] Unit of Audiology, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan

[3] Unit of Allergology and Immunology, Niguarda Ca' Granda Hospital, Milan

来源：

Clinical and Molecular Allergy | / 13卷 / 1期

关键词：

Hymenoptera venom allergy; Hymenoptera venom immunotherapy; Specific IgE levels; VIT discontinuation; VIT long-lasting protection;

D O I：

10.1186/s12948-015-0036-6

中图分类号：

学科分类号：

摘要：

Background: Venom immunotherapy (VIT) is an effective treatment for subjects with systemic allergic reactions (SR) to Hymenoptera stings, however there are few studies concerning the relevance of the venom specific IgE changes to decide about VIT cessation. We assessed IgE changes during a 5-year VIT, in patients stung and protected within the first 3 years (SP 0-3) or in the last 2 years (SP 3-5), and in patients not stung (NoS), to evaluate possible correlations between IgE changes and clinical protection. Methods: Yellow jacket venom (YJV)-allergic patients who completed 5 years of VIT were retrospectively evaluated. Baseline IgE levels and after the 3rd and the 5th year of VIT were determined; all patients were asked about field stings and SRs. Results: A total of 232 YJV-allergic patients were included and divided into the following groups: 84 NoS, 72 SP 0-3 and 76 SP 3-5. IgE levels decreased during VIT compared to baseline values (χ2 = 346.029, p < 0.001). Recent vespid stings accounted for significantly higher IgE levels despite clinical protection. IgE levels after 5 years of VIT correlated significantly with Mueller grade (F = 2.778, p = 0.012) and age (F = 6.672, p = 0.002). During follow-up from 1 to 10 years after VIT discontinuation, 35.2 % of the contacted patients reported at least one field sting without SR. Conclusions: The yellow jacket-VIT temporal stopping criterion of 5 years duration did not result in undetectable IgE levels, despite a long-lasting protection. A mean IgE decrease from 58 to 70 % was observed, and it was less marked in elderly patients or in subjects with higher Mueller grade SR. © 2015 Pravettoni et al.

引用

共 38 条

[1]

Hamilton R.G., Diagnosis and treatment of allergy to hymenoptera venoms, Curr Opin Allergy Clin Immunol, 10, pp. 323-329, (2010)

[2]

Golden D.B., Kwiterovich K.A., Kagey-Sobotka A., Lichtenstein L.M., Discontinuing venom immunotherapy: extended observations, J Allergy Clin Immunol, 101, pp. 298-305, (1998)

[3]

Golden D.B., Discontinuing venom immunotherapy, Curr Opin Allergy Clin Immunol, 1, pp. 353-356, (2001)

[4]

Graft D.F., Venom immunotherapy: when to start, when to stop, Allergy Asthma Proc, 21, pp. 113-116, (2000)

[5]

Bousquet J., Muller U.R., Dreborg S., Jarisch R., Malling H.J., Mosbech H., Urbanek R., Youlten L., Immunotherapy with hymenoptera venoms. Position paper of the Working Group on immunotherapy of the European Academy of Allergy and Clinical Immunology, Allergy, 42, pp. 401-413, (1987)

[6]

Thurnheer U., Muller U., Stoller R., Lanner A., Hoigne R., Venom immunotherapy in hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment, Allergy, 38, pp. 465-475, (1983)

[7]

Urbanek R., Forster J., Kuhn W., Ziupa J., Discontinuation of bee venom immunotherapy in children and adolescents, J Pediatr, 107, pp. 367-371, (1985)

[8]

Reisman R.E., Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis, J Allergy Clin Immunol, 92, pp. 831-836, (1993)

[9]

Muller U., Helbling A., Berchtold E., Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety, J Allergy Clin Immunol, 89, pp. 529-535, (1992)

[10]

Lerch E., Muller U.R., Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients, J Allergy Clin Immunol, 101, pp. 606-612, (1998)

← 1 2 3 4 →